Citeline Podcasts

Listen Citeline's Executive Director of Clinical Intelligence, Karen Currie and Executive Editor Commerical/R&D, Mary Jo Laffler discussing the hints and tips for entering the Citeline Awards 2023, as well as information on new categories.

Find out more on our website:

https://pharmaintelligence.informa.com/citelineawards2023

#CitelineAwards

レポート『2021年の臨床試験の総括、ポストパンデミックの世界はニューノーマルを迎えたのか（2022年11月発行）』を要約し、短い音声ファイルにまとめました。臨床試験データベース「Trialtrove」がカバーする全治療領域に関して、2021年に開始された第I～III相試験の概要と、ポストパンデミックの製薬業界に影響を及ぼす主な疾患、企業、地理的要因の分析に焦点を当てました。フルレポートをお読みになりたい方は、下記のURLからダウンロードしてください。

【日本語版】

https://images.intelligence.informa.com/Web/InformaUKLimited/%7Bed9ec7f6-a609-4057-a3ab-b3b657aa8224%7D_Clinical_Trials_Round-up_2021_PInews_JP_CMPRSD.pdf

【英語版】

https://images.intelligence.informa.com/Web/InformaUKLimited/%7B60095ba9-eb79-4c64-8612-0422e3997113%7D_Clinical_Trials_Round-up_2021_PInews_EN.pdf

★臨床試験データベース「Trialtrove」

https://pharmaintelligence.informa.com/ja-JP/products-and-services/clinical-planning/trialtrove

SK바이오팜의 오픈이노베이션 전략과 신약개발 성공요인에 대한 Scrip의 맹철영 SK바이오팜 신약개발부문장(CTO) 인터뷰 기사 내용입니다.

https://scrip.pharmaintelligence.informa.com/SC146933/SK-Biopharms-CTO-On-Diversity-In-Open-Innovation

Quick Listen: Scrip's Five Must-Know Things

https://scrip.pharmaintelligence.informa.com/SC147511/Quick-Listen-Scrips-Five-MustKnow-Things

Pink Sheet reporters and editor consider the line between therapeutic innovation and affordability, the Association for Accessible Medicines searching for a new CEO, and questions about IND regulations and drug repurposing.

Scrip’s Five Must-Know Things – 5 December 2022 by Citeline

Eyestem’s founder and CEO, Dr Jogin Desai, talks to Scrip about progress made by the firm’s experimental treatment for dry age-related macular degeneration, cell and gene therapy pricing considerations and the wider competitive landscape. The company is also developing treatments for retinitis pigmentosa and idiopathic pulmonary fibrosis.

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb provides highlights from the recent HLTH conference in Las Vegas. Reed Miller and Barnaby Pickering offer an overview of the highly competitive diabetes tech market. We also talk about digital health in Germany and Europe.

Medtech Insight articles addressing topics discussed in this episode:

HLTH Conference Promises Festival Vibe On One Big Stage; Health Equity, Women’s Health, Digital Health

https://medtech.pharmaintelligence.informa.com/MT146035/HLTH-Conference-Promises-Festival-Vibe-On-One-Big-Stage-Health-Equity-Womens-Health-Digital-Health

HLTH 2022 Roundup: Mirvie, Grail, Biofourmis, Komodo Health, Babson Diagnostics

https://medtech.pharmaintelligence.informa.com/MT146060/HLTH-2022-Roundup-Mirvie-Grail-Biofourmis-Komodo-Health-Babson-Diagnostics

HLTH 2022 Roundup: CEOs Of BD And Google Cloud On Innovation, Interoperability, AI

https://medtech.pharmaintelligence.informa.com/MT147361/HLTH-2022-Roundup-CEOs-Of-BD-And-Google-Cloud-On-Innovation-Interoperability-AI

Medtech Monthly, Ep. 4: The Future Of Diabetes Tech

https://medtech.pharmaintelligence.informa.com/MT146000/Medtech-Monthly-Ep-4-The-Future-Of-Diabetes-Tech

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。

今回取り上げた記事はこちら

The Real World Is Not Enough: Comparability Is Common Obstacle For RWE In US FDA Decisions

「（邦題意訳）リアルワールド、見えた弱点　米国FDAの承認で比較可能性がネックに」

https://pink.pharmaintelligence.informa.com/PS147051/The-Real-World-Is-Not-Enough-Comparability-Is-Common-Obstacle-For-RWE-In-US-FDA-Decisions

世界の薬事規制ニュースPink Sheet（ピンクシート）とは？

https://www.citeline.com/ja-jp/products-services/regulatory-and-compliance/pink-sheet

https://scrip.pharmaintelligence.informa.com/SC147431/Quick-Listen-Scrips-Five-MustKnow-Things